INDP

Indaptus Therapeutics (INDP)

About Indaptus Therapeutics (INDP)

Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company. It engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. The firm created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.

Details

Daily high

$0.95

Daily low

$0.89

Price at open

$0.93

52 Week High

$3.10

52 Week Low

$0.84

Market cap

11.3M

Dividend yield

0.00%

Volume

23,784

Avg. volume

21,773

P/E ratio

-.55

Indaptus Therapeutics News